Status:
COMPLETED
The Role of Stress Neuromodulators in Decision Making Under Risk (Part II)
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Stress
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
The aim of the proposed project is to combine precise pharmacological manipulation of the noradrenergic system with behavioral modeling of memory processes, and fMRI methods to study the effect of a p...
Detailed Description
Affective states like acute stress can influence cognition, i.e., memory processes. Physiologically, acute stress elicits an array of autonomic and endocrine responses, including a fast release of nor...
Eligibility Criteria
Inclusion
- right handed, high-school diploma
Exclusion
- former \& present DSM-5 axis I disorders, medication,
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT05318248
Start Date
March 1 2022
End Date
March 31 2023
Last Update
April 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charite University
Berlin, Germany